# Open-label Study of Anakinra in MPS III

> **NCT04018755** · PHASE1,PHASE2 · COMPLETED · sponsor: **Lynda E Polgreen** · enrollment: 24 (actual)

## Conditions studied

- Mucopolysaccharidosis III

## Interventions

- **BIOLOGICAL:** anakinra

## Key facts

- **NCT ID:** NCT04018755
- **Lead sponsor:** Lynda E Polgreen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-30
- **Primary completion:** 2022-07-17
- **Final completion:** 2023-03-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04018755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04018755, "Open-label Study of Anakinra in MPS III". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04018755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*